These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 5689649)

  • 1. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy.
    Hastings RC; Trautman JR
    Int J Lepr Other Mycobact Dis; 1968; 36(1):45-51. PubMed ID: 5689649
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy.
    McDougall AC; Hastings RC
    Int J Lepr Other Mycobact Dis; 1968; 36(4):456-7. PubMed ID: 5753815
    [No Abstract]   [Full Text] [Related]  

  • 3. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of DADDS in lepromatous leprosy.
    Ganapati R; Naik SS; Shah MH; Shirsat LS; Gaitonde BB
    Lepr India; 1976 Jul; 48(3):238-43. PubMed ID: 799207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
    Iyer CG; Balakrishnan S; Ramu G
    Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial negativity and reactivation (relapse) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Marques RM
    Int J Lepr Other Mycobact Dis; 1970; 38(3):250-63. PubMed ID: 4993550
    [No Abstract]   [Full Text] [Related]  

  • 7. Oily injections of dapsone; an acceptable form of treatment?
    Warndorff van Diepen T
    Lepr Rev; 1986 Mar; 57(1):70-2. PubMed ID: 3702583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diucifon and dimocifon in the combined therapy of leprosy (14-year observation)].
    Goloshchapov NM; Bazurov GI; Khromova EB; Steklovskiĭ VK; Goloshchapova FN
    Vestn Dermatol Venerol; 1988; (7):18-22. PubMed ID: 3064483
    [No Abstract]   [Full Text] [Related]  

  • 9. Repository acedapsone in leprosy chemoprophylaxis and treatment.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Lancet; 1971 Sep; 2(7723):525-6. PubMed ID: 4105668
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual reaction to intramuscular sulfone in two leprosy patients in Malaysia.
    Laing AB
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):70. PubMed ID: 7189187
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of leprosy.
    Lancet; 1971 Sep; 2(7723):534-5. PubMed ID: 4105673
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 14. Intramuscular injection of dapsone in therapy for leprosy: a new approach.
    Modderman ES; Huikeshoven H; Zuidema J; Leiker DL; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):51-6. PubMed ID: 7061179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and effective serum level of repository sulphones (DADDS) in lepromatous leprosy.
    Anand LC; Rathore BS
    Lepr India; 1979 Jul; 51(3):358-62. PubMed ID: 513651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on sulfone resistance in leprosy. I. Detection of cases.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses.
    Opromolla DV
    Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex differences in the absorption of dapsone after intramuscular injection.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):359-65. PubMed ID: 6685698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):191-6. PubMed ID: 6684645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.